Health care utilization and excess costs after pelvic fractures among older people in Germany.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 12 11 2020
accepted: 18 03 2021
pubmed: 12 4 2021
medline: 15 10 2021
entrez: 11 4 2021
Statut: ppublish

Résumé

Our study demonstrates a strong increase in utilization of inpatient health care and clear excess costs in older people in the first year after pelvic fracture, the latter even after adjustment for several confounders. Excess costs were particularly high in the first few months and mainly attributable to inpatient treatment. We aimed to estimate health care utilization and excess costs in patients aged minimum 60 years up to 1 year after pelvic fracture compared to a population without pelvic fracture. In this retrospective population-based observational study, we used routine data from a large statutory health insurance (SHI) in Germany. Patients with a first pelvic fracture between 2008 and 2010 (n=5685, 82% female, mean age 80±9 years) were frequency matched with controls (n=193,159) by sex, age at index date, and index month. We estimated health care utilization and mean total direct costs (SHI perspective) with 95% confidence intervals (CIs) using BCA bootstrap procedures for 52 weeks before and after the index date. We calculated cost ratios (CRs) in 4-week intervals after the index date by fitting mixed two-part models including adjustment for possible confounders and repeated measurement. All analyses were further stratified for men/women, in-/outpatient-treated, and major/minor pelvic fractures. Health care utilization and mean costs in the year after the index date were higher for cases than for controls, with inpatient treatment being particularly pronounced. CRs (95% CIs) decreased from 10.7 (10.2-11.1) within the first 4 weeks to 1.3 (1.2-1.4) within week 49-52. Excess costs were higher for inpatient than for outpatient-treated persons (CRs of 13.4 (12.9-13.9) and 2.3 (2.0-2.6) in week 1-4). In the first few months, high excess costs were detected for both persons with major and minor pelvic fracture. Pelvic fractures come along with high excess costs and should be considered when planning and allocating health care resources.

Identifiants

pubmed: 33839895
doi: 10.1007/s00198-021-05935-1
pii: 10.1007/s00198-021-05935-1
pmc: PMC8510957
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2061-2072

Subventions

Organisme : German Federal Ministry of Education and Research
ID : 01GY1136

Informations de copyright

© 2021. The Author(s).

Références

Injury. 2017 Apr;48(4):819-824
pubmed: 28283181
J Clin Epidemiol. 2015 Jan;68(1):44-51
pubmed: 25447352
Calcif Tissue Int. 1996 Aug;59(2):79-83
pubmed: 8687973
Am J Epidemiol. 2005 Nov 1;162(9):879-86
pubmed: 16221810
J Bone Miner Res. 2017 Sep;32(9):1789-1801
pubmed: 28272751
Age Ageing. 2014 Sep;43(5):648-53
pubmed: 24419459
J Clin Epidemiol. 2000 Dec;53(12):1258-67
pubmed: 11146273
Health Serv Res. 2018 Aug;53 Suppl 1:3125-3147
pubmed: 29315527
Osteoporos Int. 2011 Jan;22(1):47-56
pubmed: 20490782
Osteoporos Int. 2005 Apr;16(4):359-71
pubmed: 15340799
J Clin Epidemiol. 2004 Dec;57(12):1288-94
pubmed: 15617955
Osteoporos Int. 2014 Jun;25(6):1751-8
pubmed: 24676845
J Bone Miner Res. 2009 Dec;24(12):2050-5
pubmed: 19453260
J Health Serv Res Policy. 2004 Oct;9(4):197-204
pubmed: 15509405
J Bone Miner Res. 2009 Apr;24(4):681-92
pubmed: 19063680
Osteoporos Int. 2013 Feb;24(2):581-93
pubmed: 22572964
J Bone Miner Res. 2011 Oct;26(10):2419-29
pubmed: 21713989
Osteoporos Int. 2011 Oct;22(10):2633-43
pubmed: 21305268
Injury. 2005 Nov;36(11):1323-9
pubmed: 15979626
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Osteoporos Int. 2006 Feb;17(2):252-8
pubmed: 16193229
PLoS One. 2015 Sep 29;10(9):e0139078
pubmed: 26418971
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Menopause. 2009 Jan-Feb;16(1):77-83
pubmed: 18703983
Pharmacoeconomics. 2010;28(5):395-409
pubmed: 20402541
J Trauma. 2007 Nov;63(5):1066-73; discussion 1072-3
pubmed: 17993952

Auteurs

S Andrich (S)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. silke.andrich@uni-duesseldorf.de.
Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz-Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. silke.andrich@uni-duesseldorf.de.

B Haastert (B)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
mediStatistica, Neuenrade, Germany.

E Neuhaus (E)

AOK NORDWEST, Dortmund, Germany.

K Frommholz (K)

AOK NORDWEST, Dortmund, Germany.

W Arend (W)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.

C Ohmann (C)

Clinical Research Infrastructure Network (ECRIN), Düsseldorf, Germany.

J Grebe (J)

Coordination Centre for Clinical Trials, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

A Vogt (A)

Coordination Centre for Clinical Trials, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

C Brunoni (C)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.

P Jungbluth (P)

Department of Orthopaedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.

S Thelen (S)

Department of Orthopaedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.

C-M Dintsios (CM)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.

J Windolf (J)

Department of Orthopaedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.

A Icks (A)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz-Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH